Anifrolumab treatment of Singleton-Merten syndrome 2 due to a novel RIGI variant
Evan E. Hsu(Boston University), Pui Y. Lee(Boston Children's Hospital), Chrystalle Katte Carreon(Boston Children's Hospital), Amy E. Roberts(Boston Children's Hospital), Seigo Okada(Boston Children's Hospital), Casey A. Rimland(Brigham and Women's Hospital), Jian Yue(Chinese Academy of Medical Sciences & Peking Union Medical College), Qing Zhou(Sir Run Run Shaw Hospital), Michael T. Lam(Boston Children's Hospital), Charmaine Joyce Lim Ilagan(Boston Children's Hospital), Courtney E LeSon(Boston Children's Hospital), Tal Geva(Boston Children's Hospital), Rachel Weng(Boston Children's Hospital), Mary Beth F. Son(Boston Children's Hospital)
Cited by 2
Related Papers
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
|New England Journal of Medicine|2020|2.7k
Recommendations for Quantification Methods During the Performance of a Pediatric Echocardiogram: A Report From the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council
|Journal of the American Society of Echocardiography|2010|1.5k
Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands
|Nature Genetics|2017|945